Substituted (Pyrroloamino)pyridines:  Potential Agents for the Treatment of Alzheimer's Disease

Journal of Medicinal Chemistry
1996.0

Abstract

A novel series of substituted (pyrroloamino)pyridines was synthesized, and the compounds were evaluated for cholinomimetic-like properties in vitro (inhibition of [3H]quinuclidinyl benzilate binding) and in vivo (reversal of scopolamine-induced dementia) as potential agents for the treatment of Alzheimer's disease. Compounds displaying significant activity were more broadly evaluated, which revealed the presence of a desirable adrenergic component of activity. The synthesis and structure-activity relationships for this series is presented, along with the biological profiles of selected compounds.

Knowledge Graph

Similar Paper

Substituted (Pyrroloamino)pyridines:  Potential Agents for the Treatment of Alzheimer's Disease
Journal of Medicinal Chemistry 1996.0
Synthesis and Structure−Activity Relationships of N-Propyl-N-(4-pyridinyl)-1H-indol-1-amine (Besipirdine) and Related Analogs as Potential Therapeutic Agents for Alzheimer's Disease
Journal of Medicinal Chemistry 1996.0
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors
Bioorganic & Medicinal Chemistry 2014.0
Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease
Journal of Medicinal Chemistry 1995.0
Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment
European Journal of Medicinal Chemistry 2016.0
Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer’s disease
Bioorganic & Medicinal Chemistry 2020.0
Design, synthesis and evaluation of some new 4-aminopyridine derivatives in learning and memory
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors
Bioorganic & Medicinal Chemistry 2015.0
Investigations on substituted (2-aminothiazol-5-yl)(imidazo[1,2-a]pyridin-3-yl)methanones for the treatment of Alzheimer’s disease
Bioorganic & Medicinal Chemistry 2021.0
Substituted spiro [2.3′] oxindolespiro [3.2″]-5,6-dimethoxy-indane-1″-one-pyrrolidine analogue as inhibitors of acetylcholinesterase
Bioorganic & Medicinal Chemistry Letters 2010.0